Donate now, help beat IBS

My Cart | Register | Sign In

Header Image

IBS and Non-GI Functional Disorders

Share  


The Association of IBS with Other Non-gastrointestinal Functional Disorders

From the Summer 2006 issue of Digestive Health Matters

“Unexplained” Symptoms and “Functional” Disorders

Patients usually go to doctors with symptoms, not with the names of diseases or conditions (diagnoses). The doctor’s task is to make sense of the patient’s complaints within the framework of medical diagnoses and recognized diseases. This is accomplished by a process of “history taking” (interview), physical examination, and diagnostic testing. The process is completed when the symptoms are resolved into the diagnosis of a specific disease, which is then treated with varying degrees of success.

Unfortunately, this idealization of the diagnostic process is often not realized in actual clinical practice. A significant percentage of patients who consult with doctors in primary care or even specialist clinics have symptoms that remain unexplained after the diagnostic process is exhausted.[1] This is the case because modern medicine focuses on structural (often called “organic”) diseases, that is diseases that have a basis in the structure or anatomy of the body systems rather than functional disorders that have a basis in how the systems work.

Examples of structural abnormalities in the gastrointestinal tract are ulcer, inflammation, infection, and cancer. Examples of functional abnormalities are disordered motility (where nerves or muscles in any portion of the digestive tract do not function with their normal strength and coordination) and hypersensitivity to pain (where persons sense or perceive pain or discomfort more easily, or at lower levels, than is considered normal). Most diagnostic tests (laboratory tests, radiology, endoscopy, and isotope scans) are designed to identify structural problems, but not disorders of function.

There are many examples of functional disorders in the gastrointestinal (GI) tract.[2] The best studied and most common of these are irritable bowel syndrome (IBS), and non-ulcer dyspepsia or functional dyspepsia. As most patients with these disorders are aware, the results of diagnostic tests appear normal and the patient is often told that “nothing is wrong with them” or that “it’s all in their head.” In effect, the symptoms remain “unexplained,” not because they cannot be explained but because some doctors do not know how to explain them.

Functional Disorders in Various Body Systems

In the mid-19th century George Miller Beard, an American neurologist coined the term “neurasthenia” for a disorder that has also been known at times as Beard’s disease.[3] He described patients with unexplained chronic fatigue and lassitude, which he referred to as nervous exhaustion. He reported that these patients had many additional signs and symptoms, including insomnia, back pain, nervousness, anxiety, depression, headache, difficulty in concentrating, reduced sexual impulse, abdominal pain, bloating and excess gas, diarrhea, and lack of appetite. Although he described patients of both sexes, he reported that neurasthenia had a female predominance.

This was an early description of a generalized functional disorder with associated psychological elements and evidence of somatization disorder (SD). These associations have gained recognition over the years for their potential contribution to the understanding and treatment of IBS.[4] Somatization disorder is a chronic condition with multiple physical complaints or symptoms, and no recognizable physical abnormality. It is much more prevalent among women than men and usually begins at a young age (up to 30 years of age). Stress often worsens symptoms.

What is Stress?

Stress is a subjective response to stimuli that involves the mind and body. In contrast to the common interpretation of the term stress” as a psychological phenomenon, it should be understood as a biological response. The stress response can alter the way the brain and the body interact. For example, stress can increase GI symptoms by changing how the brain controls unwanted and painful sensation. Learn More

Functional disorders are prevalent in most body systems. Well-recognized examples besides IBS are fibromyalgia (FMS), the chronic fatigue syndrome (CFS), chronic pelvic pain (CPP), interstitial cystitis (IC), and temperomandibular joint pain (TMJ). Table 1 presents a partial list of non-gastrointestinal functional disorders and Table 2 presents a partial list of common unexplained symptoms.

The Coexistence of IBS with Other Functional Disorders

Many published studies have reported co-occurrence rates among the functional disorders, particularly IBS and FMS.[5-13] Estimates of the prevalence of IBS in FMS patients range from 30%[14,15] to as high as 70%.[6] Studies of FMS among IBS patients have yielded similar results.  

A study was conducted of 127 chronic fatigue patients who had a non-fatigued twin. Coexisting conditions such as fibromyalgia, IBS, TMJ, interstitial cystitis, chronic pelvic pain, tension headache, multiple chemical sensitivities and other functional disorders were significantly more prevalent in the twin with chronic fatigue syndrome than in the control twin.[11]

Up to 70% of fibromyalgia (FMS) patients have chronic fatigue syndrome (CFS)[16] and 35–70% of patients with CFS have FMS.[16,17] Fifty-eight to 92% of CFS patients have IBS.[17,18]

In a study conducted in Israel, Sperber et al. showed that 31.6% of IBS patients met the diagnostic criteria for fibromyalgia, and 32% of women with fibromyalgia also suffered from IBS.[19]

The Consequences of Coexisting Functional Syndromes

In the Israeli study associations between the co-existence of IBS and fibromyalgia and clinical and health-related quality of life variables were also assessed. In all variables investigated patients with both IBS and fibromyalgia had more severe findings than patients with IBS only or healthy controls. These variables included multiple feeling of well-being, sleep disturbances, relation of stress to symptoms, number of doctor visits, concerns about illness, and psychological distress. This was also true for the Sense of Coherence Index (a measure of ability to manage circumstances)[20] and the Functional Bowel Disorder Severity Index, a measure of IBS severity.[21]

In a systematic review Whitehead et al.[22] found that 50% of IBS patients have at least one coexisting somatic symptom and many IBS patients meet diagnostic criteria for other functional disorders. Significantly, patients with IBS and another functional disorder, in comparison with patients with IBS only, have more severe IBS symptoms, a higher rate of distress such as depression, anxiety and somatization, greater impairment of quality of life, and more illness-related work absenteeism.

Characteristics that are Common to the Various Functional Syndromes

The various functional disorders have many characteristics in common. These include:

  1. The absence of specific diagnostic laboratory tests
    a.  There is no single or combination of objective test results that yields the diagnosis
  2. Symptom-based diagnostic criteria 
    a.  Diagnosis is based on the patient’s subjective report
  3. A heavy utilization of health care services
    a.  IBS is a leading cause of health care expenditure among the GI diseases[25] even though it rarely entails hospitalization and is not life-threatening
  4. A preponderance of female patients 
    a.  Women represent 70% or more of the patient population in most studies
  5. Stress modulates the symptom experience 
    a.  Symptoms are usually made worse at times of stress
  6. Particularly among patients referred to specialist centers, there is often an associated psychological co-occurrence[22]
    a.  This includes an association with psychosocial variables such as early life experiences, social support, and skills to manage difficult circumstances
  7. Quality of life is often impaired
    a.  Patients report serious impairment of the their daily activity, social life, and 
    employment[26]
  8. Quality of sleep is often impaired
    a.  Patients reported worse quality of sleep[29]
    b.  Objective sleep studies demonstrate that these patients have non-restorative sleep[31] and next-day fatigue
  9. A common mechanism of disease may be an impaired processing by the brain of sensory information (for example, pain) from the affected organs (the gut in IBS, the musculoskeletal system in fibromyalgia)[31-33]
    a.  Neuro-imaging studies (functional MRI, PET scans) indicate that brain areas in these patients may fail to inhibit, or may even facilitate, the awareness of pain stimuli originating in the relevant body systems
  10. The doctor-patient partnership plays a central role in treatment (see below)[34]
  11. Similar therapeutic approaches (antidepressant medications, cognitive behavioral therapy, hypnosis, biofeedback) are applicable and effective in the various functional disorders (see below)

Inasmuch as the functional disorders have similarities in terms of patient characteristics, impact of illness on quality of life, psychological co-occurrence and treatment, it has been suggested that they may represent a group of illnesses sharing a common origin and process of development (pathogenesis).[6,35,36] Some authorities have suggested that their separation into separate entities is artificial[37] – a result of the division of modern medicine into medical sub-specialties.

Principles of Treatment[38]

The doctor-patient relationship – A therapeutic doctor-patient partnership is critical to successful treatment of IBS and other functional disorders. Treatment success in these disorders is related to the following:

  1. The patient’s expectations from therapy
    a.  Unrealistic expectations can lead to treatment failure. Many patients expect to be cured. In the absence of cures if the patient’s expectations are realistic there is less danger that the results will be disappointing.
  2. Formulation of the therapeutic goals
    a.  As in any chronic disorder the goals of therapy are to bring the disease under control rather than to cure it. This can be accomplished by education and reassurance, alleviation of symptoms (reduction of disease severity), and improved quality of life.
  3. Readiness on the part of the patient to enter into a therapeutic partnership
    a.  Patients often adopt a passive role with physicians, and physicians are often comfortable with this type of patient behavior. However, a therapeutic partnership is more likely to accomplish the desired goals of therapy.
  4. The physician’s skill in fostering a therapeutic relationship
    a.  The physician has to learn to listen empathetically and to acknowledge the reality of the patients’ symptoms. This can facilitate education and reassurance on the one hand, and the presentation and weighing of treatment options on the other.
  5. Continuity of care
    a.  Since these are chronic disorders, physicians and patients need continuity of care to increase the chances of achieving the agreed-upon goals of therapy.

Treatment Options

Non-pharmacologic therapy –Therapy without the use of drugs is often effective in the treatment of functional disorders. It may be particularly suited to patients with multiple unexplained symptoms and coexisting functional disorders. Hypnosis,[39,40] cognitive-behavioral therapy,[40,41] and psychodynamic-interpersonal therapy[42] are effective in IBS and the first two are effective in other functional disorders. Gut-centered hypnotherapy leads to beneficial physiological changes as well as improved cognitions.[43-46] It has been shown to have positive long term effects in IBS.[47] Cognitive-behavioral therapy treats mal-adaptive cognitions and behaviors associated with functional disorders and somatization.[39] Availability may be an issue since therapists trained in these modalities are not at hand in many centers

Pharmacologic therapy – Pharmacological (drug) therapy can be directed at specific symptoms or at the underlying mechanism of disease. The chemical mediator serotonin is involved in the transmission of pain stimuli and their processing in the central nervous system in both IBS and fibromyalgia. For this reason anti-depressant drugs, which affect the action of serotonin, are used to treat patients in both syndromes. These medications can also improve symptoms of depression, but that is not the prime reason they are prescribed. By their effect on serotonin they help reduce hypersensitivity to pain (whether it stems from the gut or the musculoskeletal system) by raising pain thresholds.

Because serotonin plays an important role in the functional disorders, pharmaceutical companies are actively attempting to develop new and specific serotonin-related drugs for these disorders.

Conclusion

Many patients suffer from more than one functional disorder. The coexistence of IBS with another functional disorder often results in a greater impairment in health-related quality of life than IBS alone. There are many features that are common to IBS and other functional disorders and the approach to treatment is similar with a strong emphasis on a therapeutic doctor-patient partnership.

Table 1. Non-gastrointestinal functional disorders*

Fibromyalgia (FMS)

Chronic fatigue syndrome (CFS)

Migraine and tension headaches

Temperomandibular joint disorder (TMJ)

Post-traumatic stress disorder (PTSD)

Chronic pelvic pain (CPP)

Interstitial cystitis and dysuria (pain on urination)

Non-cardiac chest pain (NCCP)†

Multiple chemical sensitivities

*The distinction between disorders and unexplained symptoms (see Table 2) is not always clear-cut.

In some patients NCCP has a gastrointestinal basis.

Back

Table 2. Common unexplained symptoms*

Headache

Dizziness

Palpitations

Back pain

Shortness of breath

Muscle pain

Dysuria (pain on urination)

Fatigue

Jaw pain

Dry mouth

Sleeping problems

Sexual-related disorders

      Dyspareunia (pain at intercourse)

      Exacerbation of IBS during menses

      Decreased libido (sexual drive)

Impaired (non-restorative) sleep

Somatization disorder

Psychological co-occurrence

      Depression

      Anxiety

      Panic disorder

*The distinction between disorders (see Table 1) and unexplained symptoms is not always clear-cut.

Back

References

  1. Sharpe M, Carson A. "Unexplained" somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med 2001; 134:926-30.
  2. Drossman DA. The functional gastrointestinal disorders, their diagnosis and the Rome II process. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II The Functional Gastrointestinal Disorders Diagnosis, Pathophysiology and Treatment: A Multinational Consensus. 2nd. ed. McLean, VA: Degnon Associates, 2000:1-29.
  3. Beard GM. Neurasthenia, or nervous exhaustion. Bost Med Surg J 1869; 80:217-21.
  4. North CS, Downs D, Clouse RE, et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2004; 2:787-95.
  5. Triadafilopoulos G, Simms RW, Goldenberg DL. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci 1991; 36:59-64.
  6. Veale D, Kavanagh G, Fielding JF, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol 1991; 30:220-2.
  7. Romano TJ. Coexistence of irritable bowel syndrome and fibromyalgia. W V Med J 1988; 84:16-8.
  8. Sivri A, Cindas A, Dincer F, Sivri B. Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. Clin Rheumatol 1996; 15:283-6.
  9. Lubrano E, Iovino P, Tremolaterra F, Parsons WJ, Ciacci C, Mazzacca G. Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder. Int J Colorectal Dis 2001; 16(4):211-5.
  10. Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001; 134(9 Pt 2):868-81.
  11. Aaron LA, Herrell R, Ashton S, et al. Comorbid clinical conditions in chronic fatigue: a co-twin control study. J Gen Intern Med 2001; 16:24-31.
  12. Azpiroz F, Dapoigny M, Pace F, et al. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion 2000; 62:66-72.
  13. Jones KR, Palsson OS, Levy RL, et al. Comorbid disorders and symptoms in irritable bowel syndrome (IBS) compared to other gastroenterology patients. Gastroenterology 2001; 120(Suppl 1):A66.
  14. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arth Rheum 1981; 11:151-71.
  15. Pace F, Manzionna G, Bollani S, Sarzi-Puttini P, Bianchi Porro G. Visceral sensitivity in patients with fibromyalgia and in normal patients. Gastroenterology 1997; 112:A802.
  16. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994; 154:2049-53.
  17. Goldenberg DL, Simms RW, Geiger A, Komaroff AL. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 1990; 33:381-7.
  18. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000; 160:221-7.
  19. Sperber AD, Atzmon Y, Neumann L, et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 1999; 94:3541-6.
  20. Sperber AD, Carmel S, Atzmon Y, et al. The sense of coherence index and the irritable bowel syndrome. A cross-sectional comparison among irritable bowel syndrome patients with and without coexisting fibromyalgia, irritable bowel syndrome non-patients, and controls. Scand J Gastroenterol 1999; 34:259-63.
  21. Sperber AD, Carmel S, Atzmon Y, et al. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Am J Gastroenterol 2000; 95:995-8.
  22. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122:1140-56.
  23. Palsson OS, Jones KR, Turner M, Drossman DA, Whitehead WE. Impact of somatization and comorbid medical conditions on health care utilization, disability, and quality of life in irritable bowel syndrome (IBS). Gastroenterology 2002; 122:A501-2.
  24. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004; 20:1195-203.
  25. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122:1500-11.
  26. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002; 16:1171-85.
  27. Levy RI, Whitehead WE, Von Korff MR, Feld AD. Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol 2000; 95:451-6.
  28. Drossman SA, Leserman J, Nachman N, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990; 113:828-33.
  29. Goldsmith G, Levin JS. Effect of sleep quality on symptoms of irritable bowel syndrome. Dig Dis Sci 1993; 38:1809-14.
  30. Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A, Tarasiuk A. Polysomnography and actigraphy evidence of sleep fragmentation in Irritable Bowel Syndrome. Sleep 2003; 26:747-52.
  31. Chang L, Berman S, Mayer EA, et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol 2003; 98:1354-61.
  32. Chang L, Mayer EA, FitzGerald L, Stains J, Nabiloff B. Altered perception of somatic stimulation by IBS patients with and without fibromyalgia. Gastroenterology 1997; 112:A709.
  33. Chang L, Mayer EA, Johnson T, FitzGerald LZ, Naliboff B. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000; 84:297-307.
  34. Drossman DA. Psychological sound bites: exercises in the patient-doctor relationship. Am J Gastroenterol 1997; 92:1418-23.
  35. Gruber AJ, Hudson JI, Pope HGJ. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Psychiatr Clin N Amer 1996; 19:351-69.
  36. Hudson JI, Goldenberg DL, Pope HGJ, Keck PEJ, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92:363-7.
  37. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999; 354:936-9.
  38. Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 1992; 116:1009-16.
  39. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003; 125:19-31.
  40. Toner BB, Segal CV, Emmott SD, Myran D. Cognitive-Behavioral Treatment of Irritable Bowel Syndrome. New York, NY: Guilford Publications, Inc., 1999.
  41. Toner BB, Segal ZV, Emmott S, et al. Cognitive behavior group therapy for patients with irritable bowel syndrome. Int J Group Psychother 1998; 48:215-43.
  42. Guthrie E, Creed F, Dawson D, Tomenson B. A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome. Br J Psychiatr 1993; 163:315-21.
  43. Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004; 56:271-8.
  44. Simren M, Ringstrom G, Bjornsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004; 66:233-8.
  45. Tan G, Hammond DC, Joseph G. Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action. Am J Clin Hypn 2005; 47:161-78.
  46. Houghton LA, Calvert EL, Jackson NA, Cooper P, Whorwell PJ. Visceral sensation and emotion: a study using hypnosis. Gut 2002; 51:701-4.
  47. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003; 52:1623-9.
Last modified on February 27, 2012 at 10:40:56 AM